- In April 2025, At the American Burn Association (ABA) 2025 Annual Meeting, AVITA Medical showcased 16 abstracts highlighting real-world and clinical data on its wound care portfolio, including RECELL, Cohealyx, and PermeaDerm
- In April 2025, Surgeons at The Ohio State University Wexner Medical Center became the first globally to use Cohealyx, a skin substitute designed for repairing severe burn and wound damage. This breakthrough is expected to reduce healing time and improve surgical outcomes for patients with deep tissue damage
- In March 2025, The South Carolina Burn Center at MUSC and the Zucker Institute partnered with Chitozan Health to develop advanced antimicrobial gels for burns and wounds. These gels are aimed at preventing infection and accelerating healing, particularly in severe or chronic wound cases
- In February 2025, Hamilton Health Sciences initiated a clinical trial using stem cells harvested from burned tissue to regenerate skin in patients with extensive burns. The trial incorporates 3D bioprinting, using stem cell-derived bioink to fabricate personalized skin grafts
- In January 2025, The U.S. Department of Defense’s Military Burn Research Program (MBRP) released a pre-announcement for FY2025 funding opportunities. The program supports innovations in battlefield burn care, wound healing, and long-term rehabilitation of service members with burn injuries
